Taken together, these in silico findings support the hypothesis that IVGRPLANG and IGDEPRHQYL possess multitarget potential as antihypertensive agents capable of modulating a broad range of hypertension-related pathways beyond ACE inhibition. This evidence concerns the gene ACE and hypertensive disorder.